Pfizer Inc (PFE)

Add to Watchlists
Create an Alert
44.06 +0.31  +0.71% NYSE Sep 21, 20:00 Delayed 2m USD

Pfizer Inc Research and Development Expense (Quarterly):

1.797B for June 30, 2018
View 4,000+ financial data types
View Full Chart

Pfizer Inc Research and Development Expense (Quarterly) Chart

Export Data
Save Image
Print Image

Pfizer Inc Historical Research and Development Expense (Quarterly) Data

View and export this data going back to 1984. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2018 1.797B
March 31, 2018 1.743B
Dec. 31, 2017 2.311B
Sept. 30, 2017 1.859B
June 30, 2017 1.787B
March 31, 2017 1.716B
Dec. 31, 2016 2.512B
Sept. 30, 2016 1.881B
June 30, 2016 1.748B
March 31, 2016 1.731B
Dec. 31, 2015 2.348B
Sept. 30, 2015 1.722B
June 30, 2015 1.734B
March 31, 2015 1.885B
Dec. 31, 2014 3.209B
Sept. 30, 2014 1.802B
June 30, 2014 1.759B
March 31, 2014 1.623B
Dec. 31, 2013 1.811B
Sept. 30, 2013 1.627B
June 30, 2013 1.53B
March 31, 2013 1.71B
Dec. 31, 2012 2.021B
Sept. 30, 2012 1.887B
June 30, 2012 1.60B
March 31, 2012 2.062B
Dec. 31, 2011 2.194B
Sept. 30, 2011 2.176B
June 30, 2011 2.231B
March 31, 2011 2.091B
Dec. 31, 2010 2.893B
Sept. 30, 2010 2.188B
June 30, 2010 2.181B
March 31, 2010 2.221B
Dec. 31, 2009 2.813B
Sept. 30, 2009 1.632B
June 30, 2009 1.715B
March 31, 2009 1.705B
Dec. 31, 2008 2.936B
Sept. 30, 2008 1.885B
June 30, 2008 2.122B
March 31, 2008 1.791B
Dec. 31, 2007 2.26B
Sept. 30, 2007 1.999B
June 30, 2007 2.165B
March 31, 2007 1.665B
Dec. 31, 2006 2.412B
Sept. 30, 2006 1.902B
June 30, 2006 1.742B
March 31, 2006 1.543B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About R&D Expense

R&D expenses are a line item from many companies' income statements.

R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More


PFE Research and Development Expense (Quarterly) Benchmarks

Bristol-Myers Squibb Co 2.435B
Celgene Corp 1.251B
Johnson & Johnson 2.639B

PFE Research and Development Expense (Quarterly) Range, Past 5 Years

Minimum 1.623B Mar 2014
Maximum 3.209B Dec 2014
Average 1.930B

PFE Research and Development Expense (Quarterly) Excel Add-In Codes

  • Metric Code: r_and_d_expense
  • Latest data point: =YCP("PFE", "r_and_d_expense")
  • Last 5 data points: =YCS("PFE", "r_and_d_expense", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.




Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.